Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04136951 · ClinicalTrials.gov registry record · NA
Improving Patient Prioritization During Hospital-homecare Transition
A NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,915
- Enrollment target
- 2
- Study locations
NCT04136951 is a NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure that has completed, run by Columbia University. The registered enrollment target is 1,915 participants, below the 4,480-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04136951, a NA study of Diabetes Mellitus, Type 2 and Congestive Heart Failure, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,915 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research work is focused on building and evaluating one of the first evidence-based clinical decision support tools for homecare in the United States. The results of this study have the potential to standardize and individualize nursing decision making using cutting-edge technology and to improve patient outcomes in the homecare setting.
Conditions Studied
Interventions
- OTHER PREVENT clinical decision support
Study Locations (2)
New York
- Columbia University School of Nursing - New York
- Visiting Nurse Service of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,915 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04136951
The ClinicalTrials.gov registry entry for NCT04136951 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,915 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,480-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (57% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which PREVENT clinical decision support is the first listed.
NCT04136951 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04136951 about?
NCT04136951 is a clinical study titled "Improving Patient Prioritization During Hospital-homecare Transition". This research work is focused on building and evaluating one of the first evidence-based clinical decision support tools for homecare in the United States. The results of this study have the potential to standardize and individualize nursing decision making using cutting-edge technology and to impro...
What is the current status of trial NCT04136951?
This trial is currently completed. It is a NA study. The enrollment target is 1,915 participants. The study started on 2023-08-01. Estimated completion is 2024-05-01.
What conditions does trial NCT04136951 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Congestive Heart Failure, Dyspnea, Renal Failure, Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT04136951?
The interventions under investigation include: PREVENT clinical decision support (OTHER).
Who is sponsoring clinical trial NCT04136951?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04136951 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.